Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Contribution of SLC22A12 on hypouricemia and its clinical significance for screening purposes.

Cha DH, Gee HY, Cachau R, Choi JM, Park D, Jee SH, Ryu S, Kim KK, Won HH, Limou S, Myung W, Winkler CA, Cho SK.

Sci Rep. 2019 Oct 7;9(1):14360. doi: 10.1038/s41598-019-50798-6.

2.

APOL1 Nephropathy Risk Alleles and Mortality in African American Adults: A Cohort Study.

Gutiérrez OM, Irvin MR, Zakai NA, Naik RP, Chaudhary NS, Estrella MM, Limou S, Judd SE, Cushman M, Kopp JB, Winkler CA.

Am J Kidney Dis. 2019 Sep 26. pii: S0272-6386(19)30850-9. doi: 10.1053/j.ajkd.2019.05.027. [Epub ahead of print]

PMID:
31563468
3.

Host Genetics of Cytomegalovirus Pathogenesis.

Sezgin E, An P, Winkler CA.

Front Genet. 2019 Jul 23;10:616. doi: 10.3389/fgene.2019.00616. eCollection 2019. Review.

4.

APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.

Grams ME, Surapaneni A, Ballew SH, Appel LJ, Boerwinkle E, Boulware LE, Chen TK, Coresh J, Cushman M, Divers J, Gutiérrez OM, Irvin MR, Ix JH, Kopp JB, Kuller LH, Langefeld CD, Lipkowitz MS, Mukamal KJ, Musani SK, Naik RP, Pajewski NM, Peralta CA, Tin A, Wassel CL, Wilson JG, Winkler CA, Young BA, Zakai NA, Freedman BI.

J Am Soc Nephrol. 2019 Oct;30(10):2027-2036. doi: 10.1681/ASN.2019030240. Epub 2019 Aug 5.

PMID:
31383730
5.

Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinoma.

Liao X, Wang X, Huang K, Han C, Deng J, Yu T, Yang C, Huang R, Liu X, Yu L, Zhu G, Su H, Qin W, Zeng X, Han B, Han Q, Liu Z, Zhou X, Gong Y, Liu Z, Huang J, Winkler CA, O'Brien SJ, Ye X, Peng T.

J Cancer. 2019 Jun 2;10(14):3267-3283. doi: 10.7150/jca.29986. eCollection 2019.

6.

Genetic analyses of diverse populations improves discovery for complex traits.

Wojcik GL, Graff M, Nishimura KK, Tao R, Haessler J, Gignoux CR, Highland HM, Patel YM, Sorokin EP, Avery CL, Belbin GM, Bien SA, Cheng I, Cullina S, Hodonsky CJ, Hu Y, Huckins LM, Jeff J, Justice AE, Kocarnik JM, Lim U, Lin BM, Lu Y, Nelson SC, Park SL, Poisner H, Preuss MH, Richard MA, Schurmann C, Setiawan VW, Sockell A, Vahi K, Verbanck M, Vishnu A, Walker RW, Young KL, Zubair N, Acuña-Alonso V, Ambite JL, Barnes KC, Boerwinkle E, Bottinger EP, Bustamante CD, Caberto C, Canizales-Quinteros S, Conomos MP, Deelman E, Do R, Doheny K, Fernández-Rhodes L, Fornage M, Hailu B, Heiss G, Henn BM, Hindorff LA, Jackson RD, Laurie CA, Laurie CC, Li Y, Lin DY, Moreno-Estrada A, Nadkarni G, Norman PJ, Pooler LC, Reiner AP, Romm J, Sabatti C, Sandoval K, Sheng X, Stahl EA, Stram DO, Thornton TA, Wassel CL, Wilkens LR, Winkler CA, Yoneyama S, Buyske S, Haiman CA, Kooperberg C, Le Marchand L, Loos RJF, Matise TC, North KE, Peters U, Kenny EE, Carlson CS.

Nature. 2019 Jun;570(7762):514-518. doi: 10.1038/s41586-019-1310-4. Epub 2019 Jun 19.

PMID:
31217584
7.

Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.

Aliyu MH, Wudil UJ, Ingles DJ, Shepherd BE, Gong W, Musa BM, Muhammad H, Sani MU, Abdu A, Nalado AM, Atanda A, Ahonkhai AA, Ikizler TA, Winkler CA, Kopp JB, Kimmel PL, Wester CW.

Trials. 2019 Jun 10;20(1):341. doi: 10.1186/s13063-019-3436-y.

8.

Association of sickle cell trait with atrial fibrillation: The REGARDS cohort.

Douce DR, Soliman EZ, Naik R, Hyacinth HI, Cushman M, Winkler CA, Howard G, Lange EM, Lange LA, Irvin MR, Zakai NA.

J Electrocardiol. 2019 Jul - Aug;55:1-5. doi: 10.1016/j.jelectrocard.2019.04.010. Epub 2019 Apr 16.

PMID:
31028976
9.

The Prevalence of Hyperuricemia Sharply Increases from the Late Menopausal Transition Stage in Middle-Aged Women.

Cho SK, Winkler CA, Lee SJ, Chang Y, Ryu S.

J Clin Med. 2019 Mar 2;8(3). pii: E296. doi: 10.3390/jcm8030296.

10.

Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression.

An P, Kirk GD, Limou S, Binns-Roemer E, Kopp JB, Winkler CA.

Front Immunol. 2019 Jan 24;10:53. doi: 10.3389/fimmu.2019.00053. eCollection 2019.

11.

IFITM Genes, Variants, and Their Roles in the Control and Pathogenesis of Viral Infections.

Zhao X, Li J, Winkler CA, An P, Guo JT.

Front Microbiol. 2019 Jan 8;9:3228. doi: 10.3389/fmicb.2018.03228. eCollection 2018. Review.

12.

Genetically Regulated Bilirubin and Risk of Non-alcoholic Fatty Liver Disease: A Mendelian Randomization Study.

Luo L, An P, Jia X, Yue X, Zheng S, Liu S, Chen Y, An W, Winkler CA, Duan Z.

Front Genet. 2018 Dec 18;9:662. doi: 10.3389/fgene.2018.00662. eCollection 2018.

13.

Taqman Assay for Genotyping CKD-Associated APOL1 SNP rs60910145: A Cautionary Note.

David VA, Binns-Roemer EA, Winkler CA.

Kidney Int Rep. 2018 Oct 1;4(1):184-185. doi: 10.1016/j.ekir.2018.09.018. eCollection 2019 Jan. No abstract available.

14.

Latin Americans show wide-spread Converso ancestry and imprint of local Native ancestry on physical appearance.

Chacón-Duque JC, Adhikari K, Fuentes-Guajardo M, Mendoza-Revilla J, Acuña-Alonzo V, Barquera R, Quinto-Sánchez M, Gómez-Valdés J, Everardo Martínez P, Villamil-Ramírez H, Hünemeier T, Ramallo V, Silva de Cerqueira CC, Hurtado M, Villegas V, Granja V, Villena M, Vásquez R, Llop E, Sandoval JR, Salazar-Granara AA, Parolin ML, Sandoval K, Peñaloza-Espinosa RI, Rangel-Villalobos H, Winkler CA, Klitz W, Bravi C, Molina J, Corach D, Barrantes R, Gomes V, Resende C, Gusmão L, Amorim A, Xue Y, Dugoujon JM, Moral P, González-José R, Schuler-Faccini L, Salzano FM, Bortolini MC, Canizales-Quinteros S, Poletti G, Gallo C, Bedoya G, Rothhammer F, Balding D, Hellenthal G, Ruiz-Linares A.

Nat Commun. 2018 Dec 19;9(1):5388. doi: 10.1038/s41467-018-07748-z.

15.

NPHS2 V260E Is a Frequent Cause of Steroid-Resistant Nephrotic Syndrome in Black South African Children.

Asharam K, Bhimma R, David VA, Coovadia HM, Qulu WP, Naicker T, Gillies CE, Vega-Warner V, Johnson RC, Limou S, Kopp JB, Sampson M, Nelson GW, Winkler CA.

Kidney Int Rep. 2018 Jul 29;3(6):1354-1362. doi: 10.1016/j.ekir.2018.07.017. eCollection 2018 Nov.

16.

APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R.

Okamoto K, Rausch JW, Wakashin H, Fu Y, Chung JY, Dummer PD, Shin MK, Chandra P, Suzuki K, Shrivastav S, Rosenberg AZ, Hewitt SM, Ray PE, Noiri E, Le Grice SFJ, Hoek M, Han Z, Winkler CA, Kopp JB.

Commun Biol. 2018 Nov 7;1:188. doi: 10.1038/s42003-018-0188-2. eCollection 2018.

17.

A genome-wide association and admixture mapping study of bronchodilator drug response in African Americans with asthma.

Spear ML, Hu D, Pino-Yanes M, Huntsman S, Eng C, Levin AM, Ortega VE, White MJ, McGarry ME, Thakur N, Galanter J, Mak ACY, Oh SS, Ampleford E, Peters SP, Davis A, Kumar R, Farber HJ, Meade K, Avila PC, Serebrisky D, Lenoir MA, Brigino-Buenaventura E, Cintron WR, Thyne SM, Rodriguez-Santana JR, Ford JG, Chapela R, Estrada AM, Sandoval K, Seibold MA, Winkler CA, Bleecker ER, Myers DA, Williams LK, Hernandez RD, Torgerson DG, Burchard EG.

Pharmacogenomics J. 2019 Jun;19(3):249-259. doi: 10.1038/s41397-018-0042-4. Epub 2018 Sep 12.

18.

An admixture mapping meta-analysis implicates genetic variation at 18q21 with asthma susceptibility in Latinos.

Gignoux CR, Torgerson DG, Pino-Yanes M, Uricchio LH, Galanter J, Roth LA, Eng C, Hu D, Nguyen EA, Huntsman S, Mathias RA, Kumar R, Rodriguez-Santana J, Thakur N, Oh SS, McGarry M, Moreno-Estrada A, Sandoval K, Winkler CA, Seibold MA, Padhukasahasram B, Conti DV, Farber HJ, Avila P, Brigino-Buenaventura E, Lenoir M, Meade K, Serebrisky D, Borrell LN, Rodriguez-Cintron W, Thyne S, Joubert BR, Romieu I, Levin AM, Sienra-Monge JJ, Del Rio-Navarro BE, Gan W, Raby BA, Weiss ST, Bleecker E, Meyers DA, Martinez FJ, Gauderman WJ, Gilliland F, London SJ, Bustamante CD, Nicolae DL, Ober C, Sen S, Barnes K, Williams LK, Hernandez RD, Burchard EG.

J Allergy Clin Immunol. 2019 Mar;143(3):957-969. doi: 10.1016/j.jaci.2016.08.057. Epub 2018 Sep 7.

PMID:
30201514
19.

Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry.

Reidy KJ, Hjorten RC, Simpson CL, Rosenberg AZ, Rosenblum SD, Kovesdy CP, Tylavsky FA, Myrie J, Ruiz BL, Haque S, Mozhui K, Nelson GW, David VA, Yang X, Suzuki M, Jacob J, Reznik SE, Kaskel FJ, Kopp JB, Winkler CA, Davis RL.

Am J Hum Genet. 2018 Sep 6;103(3):367-376. doi: 10.1016/j.ajhg.2018.08.002. Epub 2018 Aug 30.

20.

Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease.

Kopp JB, Winkler CA.

Semin Nephrol. 2018 Jul;38(4):317-324. doi: 10.1016/j.semnephrol.2018.05.002. Review.

PMID:
30082052
21.

Host and Viral Genetic Variation in HBV-Related Hepatocellular Carcinoma.

An P, Xu J, Yu Y, Winkler CA.

Front Genet. 2018 Jul 19;9:261. doi: 10.3389/fgene.2018.00261. eCollection 2018. Review.

22.

Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.

Franceschini N, Kopp JB, Barac A, Martin LW, Li Y, Qian H, Reiner AP, Pollak M, Wallace RB, Rosamond WD, Winkler CA.

JAMA Cardiol. 2018 Aug 1;3(8):712-720. doi: 10.1001/jamacardio.2018.1827.

23.

Effects of anthropogenic wildfire in low-elevation Pacific island vegetation communities in French Polynesia.

Newman EA, Winkler CA, Hembry DH.

PeerJ. 2018 Jun 20;6:e5114. doi: 10.7717/peerj.5114. eCollection 2018.

24.

The Loss-of-Function S267F Variant in HBV Receptor NTCP Reduces Human Risk for HBV Infection and Disease Progression.

An P, Zeng Z, Winkler CA.

J Infect Dis. 2018 Sep 22;218(9):1404-1410. doi: 10.1093/infdis/jiy355.

25.

APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults.

Gutiérrez OM, Irvin MR, Chaudhary NS, Cushman M, Zakai NA, David VA, Limou S, Pamir N, Reiner AP, Naik RP, Sale MM, Safford MM, Hyacinth HI, Judd SE, Kopp JB, Winkler CA.

Circ Genom Precis Med. 2018 Jun;11(6):e002098. doi: 10.1161/CIRCGEN.117.002098.

26.

Serum 6-Bromotryptophan Levels Identified as a Risk Factor for CKD Progression.

Tin A, Nadkarni G, Evans AM, Winkler CA, Bottinger E, Rebholz CM, Sarnak MJ, Inker LA, Levey AS, Lipkowitz MS, Appel LJ, Arking DE, Coresh J, Grams ME.

J Am Soc Nephrol. 2018 Jul;29(7):1939-1947. doi: 10.1681/ASN.2017101064. Epub 2018 May 18.

27.

Association of Sickle Cell Trait With Ischemic Stroke Among African Americans: A Meta-analysis.

Hyacinth HI, Carty CL, Seals SR, Irvin MR, Naik RP, Burke GL, Zakai NA, Wilson JG, Franceschini N, Winkler CA, David VA, Kopp JB, Judd SE, Adams RJ, Longstreth WT Jr, Egede L, Lackland DT, Taylor H, Manson JE, Howard V, Allison M, Gee BE, Correa A, Safford MM, Arnett DK, Howard G, Reiner AP, Cushman M.

JAMA Neurol. 2018 Jul 1;75(7):802-807. doi: 10.1001/jamaneurol.2018.0571.

28.

Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma.

Yang C, Su H, Liao X, Han C, Yu T, Zhu G, Wang X, Winkler CA, O'Brien SJ, Peng T.

Cancer Manag Res. 2018 Apr 10;10:679-696. doi: 10.2147/CMAR.S162595. eCollection 2018.

29.

Whole-Genome Sequencing of Pharmacogenetic Drug Response in Racially Diverse Children with Asthma.

Mak ACY, White MJ, Eckalbar WL, Szpiech ZA, Oh SS, Pino-Yanes M, Hu D, Goddard P, Huntsman S, Galanter J, Wu AC, Himes BE, Germer S, Vogel JM, Bunting KL, Eng C, Salazar S, Keys KL, Liberto J, Nuckton TJ, Nguyen TA, Torgerson DG, Kwok PY, Levin AM, Celedón JC, Forno E, Hakonarson H, Sleiman PM, Dahlin A, Tantisira KG, Weiss ST, Serebrisky D, Brigino-Buenaventura E, Farber HJ, Meade K, Lenoir MA, Avila PC, Sen S, Thyne SM, Rodriguez-Cintron W, Winkler CA, Moreno-Estrada A, Sandoval K, Rodriguez-Santana JR, Kumar R, Williams LK, Ahituv N, Ziv E, Seibold MA, Darnell RB, Zaitlen N, Hernandez RD, Burchard EG; NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium.

Am J Respir Crit Care Med. 2018 Jun 15;197(12):1552-1564. doi: 10.1164/rccm.201712-2529OC.

30.

Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Swanepoel CR, Atta MG, D'Agati VD, Estrella MM, Fogo AB, Naicker S, Post FA, Wearne N, Winkler CA, Cheung M, Wheeler DC, Winkelmayer WC, Wyatt CM; Conference Participants.

Kidney Int. 2018 Mar;93(3):545-559. doi: 10.1016/j.kint.2017.11.007. Epub 2018 Feb 3.

31.

APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death.

Hughson MD, Hoy WE, Mott SA, Bertram JF, Winkler CA, Kopp JB.

Kidney Int Rep. 2017 Aug 24;3(1):89-98. doi: 10.1016/j.ekir.2017.08.007. eCollection 2018 Jan.

32.

APOL1 Genotype and Renal Function of Black Living Donors.

Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, Kopp JB.

J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.

33.

Circulating microRNA's as a diagnostic tool for hepatocellular carcinoma in a hyper endemic HIV setting, KwaZulu-Natal, South Africa: a case control study protocol focusing on viral etiology.

Sartorius K, Sartorius B, Kramvis A, Singh E, Turchinovich A, Burwinkel B, Madiba T, Winkler CA.

BMC Cancer. 2017 Dec 28;17(1):894. doi: 10.1186/s12885-017-3915-z.

34.

APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.

Kopp JB, Heymann J, Winkler CA.

Semin Nephrol. 2017 Nov;37(6):514-519. doi: 10.1016/j.semnephrol.2017.07.004. Review.

35.

APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD.

Chen TK, Tin A, Peralta CA, Appel LJ, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.

Clin J Am Soc Nephrol. 2017 Nov 7;12(11):1771-1777. doi: 10.2215/CJN.01180117. Epub 2017 Oct 19.

36.

APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.

Gutiérrez OM, Limou S, Lin F, Peralta CA, Kramer HJ, Carr JJ, Bibbins-Domingo K, Winkler CA, Lewis CE, Kopp JB.

Kidney Int. 2018 Mar;93(3):727-732. doi: 10.1016/j.kint.2017.08.019. Epub 2017 Oct 14.

37.

Preoperative transcatheter arterial chemotherapy may suppress oxidative stress in hepatocellular carcinoma cells and reduce the risk of short-term relapse.

Su H, Zhu G, Djaja P KI, Lin Y, Gong Y, Liu X, Li J, Liu Z, Qin X, Li L, Liu T, Lu Z, Wei M, Yan L, Winkler CA, O'Brien SJ, Li J, Xiao K, Peng T.

Oncotarget. 2017 May 7;8(33):54402-54415. doi: 10.18632/oncotarget.17660. eCollection 2017 Aug 15.

38.

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease.

Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, Kopp JB, Skorecki K, Coresh J, Quyyumi AA, Sever S, Reiser J.

Nat Med. 2017 Aug;23(8):945-953. doi: 10.1038/nm.4362. Epub 2017 Jun 26.

39.

APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension).

Chen TK, Appel LJ, Grams ME, Tin A, Choi MJ, Lipkowitz MS, Winkler CA, Estrella MM.

Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1765-1769. doi: 10.1161/ATVBAHA.117.309384. Epub 2017 Jun 1.

40.

APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.

Chen TK, Estrella MM, Vittinghoff E, Lin F, Gutierrez OM, Kramer H, Lewis CE, Kopp JB, Allen NB, Winkler CA, Bibbins-Domingo KB, Peralta CA.

Kidney Int. 2017 Oct;92(4):964-971. doi: 10.1016/j.kint.2017.03.028. Epub 2017 May 23.

41.

Coxiella burnetii antibody seropositivity is not a risk factor for AIDS-related non-Hodgkin lymphoma.

Miller HK, Santo L, Camargo MC, Winkler CA, Goedert JJ, Kersh GJ, Rabkin CS.

Blood. 2017 Jun 15;129(24):3262-3264. doi: 10.1182/blood-2016-12-756569. Epub 2017 Apr 10. No abstract available.

42.

Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.

Heymann J, Winkler CA, Hoek M, Susztak K, Kopp JB.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i65-i70. doi: 10.1093/ndt/gfw402. Review.

43.

A mouse recapitulating APOL1-associated kidney disease.

Winkler CA, Nelson GW.

Nat Med. 2017 Apr 7;23(4):411-412. doi: 10.1038/nm.4318. No abstract available.

PMID:
28388606
44.

Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.

Hoy WE, Kopp JB, Mott SA, Winkler CA.

Kidney Int. 2017 Apr;91(4):990. doi: 10.1016/j.kint.2016.11.031. No abstract available.

45.

Sickle Cell Trait and the Risk of ESRD in Blacks.

Naik RP, Irvin MR, Judd S, Gutiérrez OM, Zakai NA, Derebail VK, Peralta C, Lewis MR, Zhi D, Arnett D, McClellan W, Wilson JG, Reiner AP, Kopp JB, Winkler CA, Cushman M.

J Am Soc Nephrol. 2017 Jul;28(7):2180-2187. doi: 10.1681/ASN.2016101086. Epub 2017 Mar 9.

46.

The importance of genetic factors for the development of arthropathy: a longitudinal study of children and adolescents with haemophilia A.

Gomperts ED, Schwarz J, Donfield SM, Lail AE, Astermark J, Hoots WK, Winkler CA, Berntorp E.

Thromb Haemost. 2017 Jan 26;117(2):277-285. doi: 10.1160/TH16-06-0440. Epub 2016 Dec 8.

PMID:
27929201
47.

Renal and Cardiovascular Morbidities Associated with APOL1 Status among African-American and Non-African-American Children with Focal Segmental Glomerulosclerosis.

Woroniecki RP, Ng DK, Limou S, Winkler CA, Reidy KJ, Mitsnefes M, Sampson MG, Wong CS, Warady BA, Furth SL, Kopp JB, Kaskel FJ.

Front Pediatr. 2016 Nov 17;4:122. eCollection 2016.

48.

Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study.

Parsa A, Kanetsky PA, Xiao R, Gupta J, Mitra N, Limou S, Xie D, Xu H, Anderson AH, Ojo A, Kusek JW, Lora CM, Hamm LL, He J, Sandholm N, Jeff J, Raj DE, Böger CA, Bottinger E, Salimi S, Parekh RS, Adler SG, Langefeld CD, Bowden DW; FIND Consortium, Groop PH, Forsblom C, Freedman BI, Lipkowitz M, Fox CS, Winkler CA, Feldman HI; and the Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.

J Am Soc Nephrol. 2017 Mar;28(3):923-934. doi: 10.1681/ASN.2015101152. Epub 2016 Oct 11.

49.

The Simons Genome Diversity Project: 300 genomes from 142 diverse populations.

Mallick S, Li H, Lipson M, Mathieson I, Gymrek M, Racimo F, Zhao M, Chennagiri N, Nordenfelt S, Tandon A, Skoglund P, Lazaridis I, Sankararaman S, Fu Q, Rohland N, Renaud G, Erlich Y, Willems T, Gallo C, Spence JP, Song YS, Poletti G, Balloux F, van Driem G, de Knijff P, Romero IG, Jha AR, Behar DM, Bravi CM, Capelli C, Hervig T, Moreno-Estrada A, Posukh OL, Balanovska E, Balanovsky O, Karachanak-Yankova S, Sahakyan H, Toncheva D, Yepiskoposyan L, Tyler-Smith C, Xue Y, Abdullah MS, Ruiz-Linares A, Beall CM, Di Rienzo A, Jeong C, Starikovskaya EB, Metspalu E, Parik J, Villems R, Henn BM, Hodoglugil U, Mahley R, Sajantila A, Stamatoyannopoulos G, Wee JT, Khusainova R, Khusnutdinova E, Litvinov S, Ayodo G, Comas D, Hammer MF, Kivisild T, Klitz W, Winkler CA, Labuda D, Bamshad M, Jorde LB, Tishkoff SA, Watkins WS, Metspalu M, Dryomov S, Sukernik R, Singh L, Thangaraj K, Pääbo S, Kelso J, Patterson N, Reich D.

Nature. 2016 Oct 13;538(7624):201-206. doi: 10.1038/nature18964. Epub 2016 Sep 21.

50.

Genomic approaches to the burden of kidney disease in Sub-Saharan Africa: the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network.

Osafo C, Raji YR, Olanrewaju T, Mamven M, Arogundade F, Ajayi S, Ulasi I, Salako B, Plange-Rhule J, Mengistu Y, Mc'Ligeyo SO, Moturi G, Winkler CA, Moxey-Mims MM, Rasooly RS, Kimmel P, Adu D, Ojo A, Parekh RS; H3Africa Kidney Disease Research Network.

Kidney Int. 2016 Jul;90(1):2-5. doi: 10.1016/j.kint.2015.12.059. No abstract available.

Supplemental Content

Loading ...
Support Center